SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-21-001717
Filing Date
2021-02-25
Accepted
2021-02-25 07:33:05
Documents
106
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K acrs-20201231x10k.htm   iXBRL 10-K 3131775
2 EX-4.2 acrs-20201231xex4d2.htm EX-4.2 28936
3 EX-10.12 acrs-20201231xex10d12.htm EX-10.12 15134
4 EX-10.16 acrs-20201231xex10d16.htm EX-10.16 155443
5 EX-21.1 acrs-20201231xex21d1.htm EX-21.1 7285
6 EX-23.1 acrs-20201231xex23d1.htm EX-23.1 3438
7 EX-31.1 acrs-20201231xex31d1.htm EX-31.1 9619
8 EX-31.2 acrs-20201231xex31d2.htm EX-31.2 9074
9 EX-32.1 acrs-20201231xex32d1.htm EX-32.1 9296
  Complete submission text file 0001558370-21-001717.txt   12820127

Data Files

Seq Description Document Type Size
10 EX-101.SCH acrs-20201231.xsd EX-101.SCH 73737
11 EX-101.CAL acrs-20201231_cal.xml EX-101.CAL 94271
12 EX-101.DEF acrs-20201231_def.xml EX-101.DEF 314923
13 EX-101.LAB acrs-20201231_lab.xml EX-101.LAB 766343
14 EX-101.PRE acrs-20201231_pre.xml EX-101.PRE 562228
15 EXTRACTED XBRL INSTANCE DOCUMENT acrs-20201231x10k_htm.xml XML 2515582
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37581 | Film No.: 21676426
SIC: 2834 Pharmaceutical Preparations